Lisata Therapeutics Statistics

Total Valuation

LSTA has a market cap or net worth of $24.27 million. The enterprise value is -$11.73 million.

Market Cap	24.27M
Enterprise Value	-11.73M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

LSTA has 8.32 million shares outstanding. The number of shares has increased by 3.19% in one year.

Current Share Class	8.32M
Shares Outstanding	8.32M
Shares Change (YoY)	+3.19%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	16.29%
Owned by Institutions (%)	9.21%
Float	6.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.72
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.03

Current Ratio	8.03
Quick Ratio	7.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.15% and return on invested capital (ROIC) is -33.94%.

Return on Equity (ROE)	-48.15%
Return on Assets (ROA)	-30.49%
Return on Capital (ROIC)	-33.94%
Revenue Per Employee	n/a
Profits Per Employee	-$829,600
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-798,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.42% in the last 52 weeks. The beta is 1.22, so LSTA's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	+27.42%
50-Day Moving Average	2.93
200-Day Moving Average	3.05
Relative Strength Index (RSI)	51.82
Average Volume (20 Days)	19,301

Short Selling Information

The latest short interest is 17,064, so 0.21% of the outstanding shares have been sold short.

Short Interest	17,064
Short Previous Month	23,812
Short % of Shares Out	0.21%
Short % of Float	0.25%
Short Ratio (days to cover)	1.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.49M
Pretax Income	-23.18M
Net Income	-20.74M
EBITDA	-23.31M
EBIT	-23.49M
Earnings Per Share (EPS)	-$2.51

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	35.86M
Total Debt	n/a
Net Cash	35.86M
Net Cash Per Share	$4.31
Equity (Book Value)	33.44M
Book Value Per Share	4.05
Working Capital	33.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-18.90M
Capital Expenditures	n/a
Free Cash Flow	-18.90M
FCF Per Share	-$2.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LSTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.19%
Shareholder Yield	-3.19%
Earnings Yield	-85.44%
FCF Yield	-77.85%

Analyst Forecast

The average price target for LSTA is $15.00, which is 414.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	414.09%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.98%

Stock Forecasts

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1